MASHINIi

HilleVax, Inc..

HLVX.US | Manufacture of pharmaceuticals, medicinal chemical and botanical products

HilleVax, Inc. is a biopharmaceutical company focused on developing and commercializing novel vaccines. Their primary focus is on norovirus, a leading cause of acute gastroenteritis. The company's lead product candidate is HIL-214, an investigational virus-like particle (VLP) vaccine designed to tar...Show More

Ethical Profile

Mixed.

HilleVax, Inc. (HLVX.US) is developing HIL-214, a norovirus vaccine, directly addressing a significant public health need, particularly for vulnerable populations. This core mission strongly aligns with "Better Health for All." However, the company's overall ethical profile is mixed. Vaccine development inherently involves animal testing, with critics noting this as a potential conflict with "Kind to Animals" values; transparency on specific protocols and commitment to alternatives is key. Additionally, robust data on fair pay, ethical sourcing, honest business practices, and environmental impact is largely unavailable, making a comprehensive assessment challenging. Patient data privacy in clinical trials is also a critical area for responsible conduct.

Value Scores

Better Health for All0
-100100
Fair Money & Economic Opportunity0
-100100
Fair Pay & Worker Respect0
-100100
Fair Trade & Ethical Sourcing0
-100100
Honest & Fair Business0
-100100
Kind to Animals-30
-100100
No War, No Weapons0
-100100
Planet-Friendly Business0
-100100
Respect for Cultures & Communities0
-100100
Safe & Smart Tech0
-100100
Zero Waste & Sustainable Products0
-100100

Better Health for All

0

No evidence available to assess HilleVax, Inc. on Better Health for All.

Fair Money & Economic Opportunity

0

The provided articles do not contain any specific, concrete data points relevant to the 'Fair Money & Economic Opportunity' value for HLVX.US. explicitly states it does not contain relevant data, and indicates no data is available.

1
Therefore, all KPIs for this value must be omitted as there is no evidence from the articles to support any score, including a '0' score for non-applicability.

Fair Pay & Worker Respect

0

No specific, quantifiable data points were found across the provided articles for any of the KPIs related to Fair Pay & Worker Respect. Information regarding living wage coverage, CEO to median pay ratio, collective bargaining share, safety incident rate, pay equity ratio, worker engagement score, voluntary turnover rate, labor violation incidents, insecure contract share, or health insurance coverage for the general workforce was not available.

1
While workforce reductions were mentioned, these are involuntary and do not provide data for voluntary turnover.
2
Executive compensation details were present, but median employee compensation was not, preventing calculation of the pay ratio.
3
Mentions of COBRA continuation coverage were related to post-merger benefits for current and former employees, not the percentage of the current workforce with employer-funded health insurance.
4

Fair Trade & Ethical Sourcing

0

No evidence available to assess HilleVax, Inc. on Fair Trade & Ethical Sourcing.

Honest & Fair Business

0

No relevant data was found in the provided article to assess HilleVax, Inc. against the 'Honest & Fair Business' ethical value.

1
The article explicitly stated that the content could not be retrieved, and no data on HLVX.US or the ethical value could be extracted.
2

Kind to Animals

-30

HilleVax, Inc. does not explicitly mention animal testing policies in its Code of Conduct and Ethics.

1
The company performs preclinical laboratory tests and animal studies, submitting data from these studies to the FDA as part of an IND, in accordance with the FDA’s Good Laboratory Practice requirements (GLPs).
2
The company mentions using *in vitro* studies in preclinical development, indicating some use of non-animal methods, primarily for early-stage toxicity screens.
3
The company's business model does not involve animal agriculture operations or sourcing eggs, meat, or dairy, making these KPIs not applicable.
4

No War, No Weapons

0

HilleVax, Inc. is a clinical-stage biopharmaceutical company focused on vaccine development.

1
The company is not involved in arms or defense contracts, and therefore has no revenue from such activities.
2
Its core business does not involve dual-use technologies with military applications, nor does it have any defense-related business to oversee or assets to divest.
3
The company has no exposure to controversial weapons.
4

Planet-Friendly Business

0

The provided articles do not contain any specific, quantitative data points for HilleVax, Inc. (HLVX.US) that are relevant to the 'Planet-Friendly Business' KPIs. While general ESG risk ratings are mentioned (e.g., 28.8, 28.81, or 29, categorized as Medium risk),

1
these are not concrete metrics that can be mapped to the quantitative thresholds of the rubric's KPIs, such as greenhouse gas emissions, renewable energy usage, water consumption, or waste diversion. There is no information on specific environmental programs, targets, certifications, or compliance records.
2

Respect for Cultures & Communities

0

No specific, concrete data points or facts were found in the provided articles regarding HLVX.US's performance on any of the KPIs related to Respect for Cultures & Communities. The articles either pertained to other entities, explicitly stated no data was available for HLVX.US on these topics, or focused solely on vaccine development without addressing social responsibility metrics.

1

Safe & Smart Tech

0

No evidence available to assess HilleVax, Inc. on Safe & Smart Tech.

Zero Waste & Sustainable Products

0

No specific, quantitative data related to waste diversion, product recyclability, packaging sustainability, recycled content, single-use plastic reduction, take-back programs, circular design, waste reduction initiatives, hazardous waste management, product durability, repairability, waste audit frequency, zero-waste certification, waste disposal violations, material efficiency, packaging-to-product ratio, waste reduction targets, supplier waste requirements, or customer waste education was found in the provided articles for HilleVax, Inc.

1
The articles explicitly state a significant data gap regarding the company's sustainability practices and zero-waste metrics.
2

Own HilleVax, Inc.?

Upload your portfolio and see how all your holdings score across 11 ethical dimensions.

Audit My Portfolio

AI-generated analysis based on publicly available data. Not financial advice. Ratings are expressions of opinion derived from automated models and may contain inaccuracies. See our Risk Disclosure for full details.